Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism

Please follow the resource link below to the guidance on 'Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism' Clive Kearonand Elie A. AklMarch 20, 2014; Blood: 123 (12)

NICE Pathway - Venous thromboembolism

This interactive flowchart covers:

  • assessing and reducing the risk of venous thromboembolism (VTE) in patients admitted to hospital
  • diagnosing VTE in primary, secondary and tertiary care, including Wells score, D-dimer measurement, ultrasound and radiological imaging
  • treating VTE
  • investigations for cancer and testing for thrombophilia in patients diagnosed with VTE.
NICE Guideline (CG144): Venous thromboembolic diseases: diagnosis, management and thrombophilia testing

This clinical guideline offers evidence-based advice on the diagnosis and management of venous thromboembolic diseases, investigations for cancer in patients with venous thromboembolism and the role of thrombophilia testing.

NICE Guideline (NG89): Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism

This guideline covers assessing and reducing the risk of venous thromboembolism (VTE or blood clots) and deep vein thrombosis (DVT) in people aged 16 and over in hospital. It aims to help healthcare professionals identify people most at risk and describes interventions that can be used to reduce the risk of VTE.

NICE CKS - Deep Vein Thrombosis

This NICE clinical knowledge summary covers the management of people with deep vein thrombosis including the duration of anticoagulation.

Expand all